Search by Drug Name or NDC
NDC 00071-0532-23 Accupril 20 mg/1 Details
Accupril 20 mg/1
Accupril is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Parke-Davis Div of Pfizer Inc. The primary component is QUINAPRIL HYDROCHLORIDE.
MedlinePlus Drug Summary
Quinapril is used alone or in combination with other medications to treat high blood pressure. It is used in combination with other medications to treat heart failure. Quinapril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels, so blood flows more smoothly and the heart can pump blood more efficiently. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 00071-0532-23Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Quinapril
Product Information
| NDC | 00071-0532 |
|---|---|
| Product ID | 0071-0532_5ff434c1-ca62-447d-b49c-31209efca983 |
| Associated GPIs | 36100040100320 |
| GCN Sequence Number | 018773 |
| GCN Sequence Number Description | quinapril HCl TABLET 20 MG ORAL |
| HIC3 | A4D |
| HIC3 Description | ANTIHYPERTENSIVES, ACE INHIBITORS |
| GCN | 27571 |
| HICL Sequence Number | 007631 |
| HICL Sequence Number Description | QUINAPRIL HCL |
| Brand/Generic | Brand |
| Proprietary Name | Accupril |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | quinapril hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | QUINAPRIL HYDROCHLORIDE |
| Labeler Name | Parke-Davis Div of Pfizer Inc |
| Pharmaceutical Class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA019885 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00071-0532-23 (00071053223)
| NDC Package Code | 0071-0532-23 |
|---|---|
| Billing NDC | 00071053223 |
| Package | 90 TABLET, FILM COATED in 1 BOTTLE (0071-0532-23) |
| Marketing Start Date | 1991-11-19 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |